Meyer L - Search Results

1

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, de Wolf F, Bucher HC, Elzi L, Touloumi G, Vourli G, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Abgrall S, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration. Cain LE, et al. Among authors: meyer l. AIDS. 2012 Aug 24;26(13):1691-705. doi: 10.1097/QAD.0b013e328354f497. AIDS. 2012. PMID: 22546987 Free PMC article.

2

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group. Harzic M, et al. Among authors: meyer l. AIDS. 2002 Mar 29;16(5):793-6. doi: 10.1097/00002030-200203290-00017. AIDS. 2002. PMID: 11964538 No abstract available.

3

Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort.

Desquilbet L, Deveau C, Goujard C, Hubert JB, Derouineau J, Meyer L; PRIMO Cohort Study Group. Desquilbet L, et al. Among authors: meyer l. AIDS. 2002 Nov 22;16(17):2329-33. doi: 10.1097/00002030-200211220-00014. AIDS. 2002. PMID: 12441806

4

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M. Lacabaratz-Porret C, et al. Among authors: meyer l. J Infect Dis. 2003 Mar 1;187(5):748-57. doi: 10.1086/368333. Epub 2003 Feb 18. J Infect Dis. 2003. PMID: 12599048 Clinical Trial.

5

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

Chaix ML, Descamps D, Harzic M, Schneider V, Deveau C, Tamalet C, Pellegrin I, Izopet J, Ruffault A, Masquelier B, Meyer L, Rouzioux C, Brun-Vezinet F, Costagliola D. Chaix ML, et al. Among authors: meyer l. AIDS. 2003 Dec 5;17(18):2635-43. doi: 10.1097/00002030-200312050-00011. AIDS. 2003. PMID: 14685058

6

Does transient HAART during primary HIV-1 infection lower the virological set-point?

Desquilbet L, Goujard C, Rouzioux C, Sinet M, Deveau C, Chaix ML, Séréni D, Boufassa F, Delfraissy JF, Meyer L; PRIMO and SEROCO Study Groups. Desquilbet L, et al. Among authors: meyer l. AIDS. 2004 Dec 3;18(18):2361-9. AIDS. 2004. PMID: 15622312

7

Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L; SEROCO Study Group. Madec Y, et al. Among authors: meyer l. Clin Infect Dis. 2005 May 1;40(9):1350-4. doi: 10.1086/429318. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825038

8

Influence of the R22H variant of macrophage inflammatory protein 1beta/Lag-1 in HIV-1 survival.

Capoulade-Métay C, Meyer L, Tran T, Persoz A, Bourdais A, Dudoit Y, Delfraissy JF, Debré P, Theodorou I. Capoulade-Métay C, et al. Among authors: meyer l. AIDS. 2005 May 20;19(8):831-3. doi: 10.1097/01.aids.0000168979.97584.18. AIDS. 2005. PMID: 15867499

9

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, Séréni D, Viard JP, Delfraissy JF, Meyer L; SEROCO Cohort Study Group. Rouzioux C, et al. Among authors: meyer l. J Infect Dis. 2005 Jul 1;192(1):46-55. doi: 10.1086/430610. Epub 2005 May 31. J Infect Dis. 2005. PMID: 15942893

10

Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.

Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA. Geskus RB, et al. Among authors: meyer l. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):321-6. doi: 10.1097/01.qai.0000142017.25897.06. J Acquir Immune Defic Syndr. 2005. PMID: 15980693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,233 results

Search Page